Literature DB >> 3592122

The genetic implications of long-term survival of childhood cancer. A conceptual framework.

L C Strong, W R Williams.   

Abstract

This article outlines a conceptual framework for considering the genetic implications of childhood cancer and taking into account genetic predisposition as well as the genotoxic effects of cancer treatment. The primary consequences by which genetic effects are measured are somatic genetic damage, second tumors in the proband, germline genetic damage, and reproductive outcomes. Studies of retinoblastoma and rhabdomyosarcoma are offered as models for examining the etiology of genetic effects and defining the risks for a second malignant neoplasm. The conclusion from these studies is that there is a small subgroup of patients for whom the genetic implications of long-term survival are significant. Characteristics of this subgroup and the risks involved in treatment are defined. More optimistically, the data indicate that for the majority of patients, the risks involved in mutagenic and carcinogenic agents used in the treatment of childhood cancer are small. The authors conclude that treatment-related effects vary according to the genetic background of the proband.

Entities:  

Mesh:

Year:  1987        PMID: 3592122     DOI: 10.1097/00043426-198721000-00017

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  8 in total

1.  Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.

Authors:  Seung Jun Shin; Jialu Li; Jing Ning; Jasmina Bojadzieva; Louise C Strong; Wenyi Wang
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

2.  Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.

Authors:  Gang Peng; Jasmina Bojadzieva; Mandy L Ballinger; Jialu Li; Amanda L Blackford; Phuong L Mai; Sharon A Savage; David M Thomas; Louise C Strong; Wenyi Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-30       Impact factor: 4.254

Review 3.  The iatrogenic leukaemias induced by radio- and/or chemotherapy.

Authors:  Y Najean
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

4.  Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.

Authors:  Shih-Jen Hwang; Guillermina Lozano; Christopher I Amos; Louise C Strong
Journal:  Am J Hum Genet       Date:  2003-02-27       Impact factor: 11.025

Review 5.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.

Authors:  Shenying Fang; Ralf Krahe; Guillermina Lozano; Younghun Han; Wei Chen; Sean M Post; Baili Zhang; Charmaine D Wilson; Linda L Bachinski; Louise C Strong; Christopher I Amos
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.

Authors:  Seung Jun Shin; Elissa B Dodd-Eaton; Gang Peng; Jasmina Bojadzieva; Jingxiao Chen; Christopher I Amos; Megan N Frone; Payal P Khincha; Phuong L Mai; Sharon A Savage; Mandy L Ballinger; David M Thomas; Ying Yuan; Louise C Strong; Wenyi Wang
Journal:  Cancer Res       Date:  2019-11-12       Impact factor: 12.701

8.  Gastric cancer in individuals with Li-Fraumeni syndrome.

Authors:  Serena Masciari; Akriti Dewanwala; Elena M Stoffel; Gregory Y Lauwers; Hui Zheng; Maria Isabel Achatz; Douglas Riegert-Johnson; Lenka Foretova; Edaise M Silva; Lisa Digianni; Sigitas J Verselis; Katherine Schneider; Frederick P Li; Joseph Fraumeni; Judy E Garber; Sapna Syngal
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.